tiotropium bromide


Also found in: Dictionary, Wikipedia.
Related to tiotropium bromide: Tiotropium bromide monohydrate

tiotropium bromide

(tī′ō-trō′pē-əm)
n.
An anticholinergic compound used as an inhalant in the treatment of chronic obstructive pulmonary disease.

tiotropium bromide

A long-acting muscarinic receptor antagonist used to treat chronic obstructive pulmonay disease (COPD). A brand name is Spiriva.
Mentioned in ?
References in periodicals archive ?
Written and verbal instructions were provided to the patient to continue all medications at home, including her hydrochlorothiazide (HCTZ) 50 mg PO daily, Lasix 40 mg PO daily, lisinopril 20 mg PO daily, metoprolol succinate 100 mg PO daily (The Joint Commission, 2013), tiotropium bromide 18 meg capsule inhaled once daily, and Klor-Con[R] 40 mEq PO daily.
The first thing to do is to check if you are using an inhaler which has Salmeterol, Formoterol or Tiotropium bromide as the only active ingredient.
Tiotropium bromide triple combination therapy improves lung function and decreases asthma exacerbations.
According to the study, adding tiotropium bromide to low doses of inhaled corticosteroids is more effective at controlling asthma than doubling inhaled corticosteroids alone, and as effective as adding the long-acting beta agonist salmeterol.
Tiotropium bromide inhalation powder is indicated once daily for the long-term, maintenance treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
Moving GSP 304 into phase II is a great example of that focus and, if approved, it will be the first nebulised form of tiotropium bromide.
On the second test day, the same measurements were obtained from the same patient after administration of a single dose 18 [micro]g of tiotropium bromide dry powder capsule delivered via the HandiHaler[R].
8%) receiving either inhaled tiotropium bromide or ipratropium bromide for more than 30 days, compared with 86 of 7,311 patients (1.
The choices are the anticholinergics ipratropium bromide and tiotropium bromide and the shortand long-acting/[beta]-agonists.
This new patent covers PUR0200, an inhaled drug made by combining Pulmatrix's technology platform with tiotropium bromide.
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.
Regular use of the inhaled anticholinergic tiotropium bromide did not significantly reduce the rate of decline in mean forced expiratory volume in 1 second in patients with chronic obstructive pulmonary disease, a large randomized, double-blind trial has shown.